Correction: An MDM2 degrader for treatment of acute leukemias

被引：0
|
作者：
Bridget K. Marcellino
Xiaobao Yang
H. Ümit Kaniskan
Claudia Brady
He Chen
Karie Chen
Xing Qiu
Cara Clementelli
Lauren Herschbein
Zhijun Li
Sebastian Elghaity-Beckley
Joann Arandela
Brianna Kelly
Ronald Hoffman
Jing Liu
Yue Xiong
Jian Jin
Alan H. Shih
机构：
[1] Icahn School of Medicine at Mount Sinai (ISMMS),Department of Medicine, Division of Hematology Oncology and Tisch Cancer Institute (TCI)
[2] Tisch Cancer Institute (TCI) Icahn School of Medicine at Mount Sinai (ISMMS),Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences, and Neuroscience
[3] New York,undefined
[4] University of North Carolina at Chapel Hill,undefined
[5] Cullgen Inc.,undefined
来源：
Leukemia | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1764 / 1765
页数：1
相关论文
共 50 条
  • [1] An MDM2 degrader for treatment of acute leukemias
    Marcellino, Bridget K.
    Yang, Xiaobao
    Kaniskan, H. Umit
    Brady, Claudia
    Chen, He
    Chen, Karie
    Qiu, Xing
    Clementelli, Cara
    Herschbein, Lauren
    Li, Zhijun
    Elghaity-Beckley, Sebastian
    Arandela, Joann
    Kelly, Brianna
    Hoffman, Ronald
    Liu, Jing
    Xiong, Yue
    Jin, Jian
    Shih, Alan H.
    LEUKEMIA, 2023, 37 (02) : 370 - 378
  • [2] An MDM2 degrader for treatment of acute leukemias
    Bridget K. Marcellino
    Xiaobao Yang
    H. Ümit Kaniskan
    Claudia Brady
    He Chen
    Karie Chen
    Xing Qiu
    Cara Clementelli
    Lauren Herschbein
    Zhijun Li
    Sebastian Elghaity-Beckley
    Joann Arandela
    Brianna Kelly
    Ronald Hoffman
    Jing Liu
    Yue Xiong
    Jian Jin
    Alan H. Shih
    Leukemia, 2023, 37 : 370 - 378
  • [3] Development of an MDM2 Degrader for Treatment of Acute Leukemias
    Marcellino, Bridget
    Yang, Xiaobao
    Chen, He
    Chen, Karie
    Brady, Claudia
    Clementelli, Cara
    Li, Zhijun
    Hoffman, Ronald
    Liu, Jing
    Kaniskan, H. Umit
    Xiong, Yue
    Jin, Jian
    Shih, Alan H.
    BLOOD, 2021, 138 : 1866 - +
  • [4] An MDM2 degrader for treatment of acute leukemias (vol 37, pg 370, 2023)
    Marcellino, Bridget K.
    Yang, Xiaobao
    Kaniskan, H. Umit
    Brady, Claudia
    Chen, He
    Chen, Karie
    Qiu, Xing
    Clementelli, Cara
    Herschbein, Lauren
    Li, Zhijun
    Elghaity-Beckley, Sebastian
    Arandela, Joann
    Kelly, Brianna
    Hoffman, Ronald
    Liu, Jing
    Xiong, Yue
    Jin, Jian
    Shih, Alan H.
    LEUKEMIA, 2023, 37 (08) : 1764 - 1765
  • [5] Orally bioavailable PROTAC based MDM2 degrader
    Aguilar, Angelo
    Yang, Jiuling
    Li, Yangbing
    McEachern, Donna
    Wang, Shaomeng
    CANCER RESEARCH, 2024, 84 (06)
  • [6] A MDM2 degrader inhibits cell proliferation and growth of MDM2-overexpressing acute lymphoblastic leukemia in SCID mice
    Liu, Tao
    Gu, Lubing
    Mui, Anna
    Wu, Zhongzhi
    Li, Wei
    Zhou, Muxiang
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Development of KT-253, a Highly Potent and Selective Heterobifunctional MDM2 Degrader for the Treatment of Acute Myeloid Leukemia
    Mayo, Michele
    Chutake, Yogesh
    Karnik, Rahul
    McDonald, Alice
    Cho, Patricia S.
    Filiatrault, Jessica
    Chen, Dapeng
    Dixit, Vaishali
    Proctor, William
    Breitkopf, Susanne
    Qi, Frank
    Hu, Kan-Nian
    Sharma, Kirti
    Ewesuedo, Reggie
    Weiss, Matt
    Growney, Joseph D.
    Williams, Juliet
    Schalm, Stefanie S.
    BLOOD, 2022, 140 : 6239 - 6240
  • [8] Predictive Markers of Response to the MDM2 Degrader KT-253
    Dumont, N.
    Karnik, R.
    Chutake, Y.
    Dey, J.
    Breitkopf, S.
    Howarth, C.
    Meeske, C.
    Fasciano, A.
    Ghilu, S.
    Houghton, P.
    Mosher, R.
    Gollob, J.
    Williams, J.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S111 - S112
  • [9] Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias
    Wojcik, I
    Szybka, M
    Golanska, E
    Rieske, P
    Blonski, JZ
    Robak, T
    Bartkowiak, J
    NEOPLASMA, 2005, 52 (04) : 318 - 324
  • [10] An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/ tissues
    Liu, Tao
    Gu, Lubing
    Mui, Anna
    Wu, Zhongzhi
    Albadari, Najah
    Li, Wei
    Zhou, Muxiang
    CANCER LETTERS, 2024, 598
12345